We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
1 watching
Current Price
$6.91
$-0.05
(-0.67%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
132.8M
52-Week High
12.7276
52-Week Low
4.6288
Average Volume
0.03M
Dividend Yield
--
P/E Ratio
--
Market Capitalization132.8M
52-Week High12.7276
52-Week Low4.6288
Average Volume0.03M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient s innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Globe Newswire
4days ago
INmuneBio, a leader in novel therapies and innovative trial design for AD participates in 15thCTAD conference in San Francisco November 29th to December 2nd Boca Raton, Florida, Nov. 29, 2022 (GLOBE NEWSWIRE) -- INmuneBio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused...
Globe Newswire
19days ago
BOCA RATON, FL., Nov. 14, 2022 (GLOBE NEWSWIRE) -- INmuneBio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announces that Health Canada has issued the Company a No ...
Globe Newswire
1month ago
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Oct. 26, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the Company), a clinical-stage immunology company focused ondeveloping treatments that harness a patients innate immune system to fight ...
Globe Newswire
2 months ago
Boca Raton, FL, Sept. 07, 2022 (GLOBE NEWSWIRE) -- INmune Bio (NASDAQ: INMB), a clinical- stage immunology company focused on developing treatments that harness the patients immune system to fight disease, announced today that RJ Tesi, M.D., Chief Executive Officer will present a corporate overview ...
Globe Newswire
4 months ago
Alzheimer's Association International Conference ("AAIC") Systems Biology of Alzheimer's Disease Panel on August 4, 2022 Moderated by Jeffrey Cummings, MD, ScD, and Krista Lanctt, Ph.D. BTIG Biotechnology Conference Fireside Conversation re the Role of Inflammation and Existing Treatments in ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$6.91
$-0.05
(-0.67%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00